Northern Trust
TVGN icon

Northern Trust’s Tevogen Inc. Common Stock TVGN Stock Holding History

Northern Trust’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,904
Closed -$64.6K – 4549
2025
Q4 		$64.6K Buy
3,904
+105
+3% +$2.73K ﹤0.01% 4228
2025
Q3 		$149K Sell
3,799
-65
-2% -$3.2K ﹤0.01% 4056
2025
Q2 		$241K Buy
3,864
+691
+22% +$39.4K ﹤0.01% 3871
2025
Q1 		$171K Buy
3,173
+805
+34% +$53K ﹤0.01% 3986
2024
Q4 		$122K Buy
2,368
+272
+13% +$17.7K ﹤0.01% 4116
2024
Q3 		$38.6K Buy
+2,096
New +$61.3K ﹤0.01% 4252

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust's TVGN Position: Q1 2026 in Review

Northern Trust sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2026, closing a stake of 3,904 shares — an estimated $64.6K sold.

Northern Trust first reported a position in TVGN in Q3 2024 and held it in 6 quarters. The position peaked at $241K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Northern Trust reported no remaining Tevogen Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 3,904 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $64.6K.
  • Northern Trust first reported a position in Tevogen Inc. Common Stock in Q3 2024 and held it in 6 quarters.
  • Northern Trust's Tevogen Inc. Common Stock position peaked at $241K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.